Attendo AB (publ) ATT.ST
Nasdaq Stockholm · Healthcare · Medical Care Facilities
130.50 SEK
+16.2%
2026-11-06
Keep this stock on your watchlist and set email alerts for prices, reports and important announcements where available.
Annual accounts for Attendo
| SEK million | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|
| Income statement | ||||
| Revenue | 14,496 | 17,287 | 18,980 | 18,991 |
| EBITDA | 2,176 | 3,053 | 3,443 | 3,884 |
| Net income | −45 | 376 | 450 | 813 |
| Balance sheet | ||||
| Equity | 5,001 | 5,363 | 5,333 | 5,445 |
| Total debt | 14,805 | 14,748 | 16,743 | 16,437 |
| Cash | 507 | 922 | 821 | 1,269 |
| Net debt | 14,298 | 13,826 | 15,922 | 15,168 |
| Ratios and per share | ||||
| EBITDA margin | 15.0% | 17.7% | 18.1% | 20.5% |
| Profit margin | −0.3% | 2.2% | 2.4% | 4.3% |
| Return on equity | −0.9% | 7.0% | 8.4% | 14.9% |
| Earnings/share (SEK) | −0.28 | 2.34 | 2.94 | 5.57 |
| Book value/share (SEK) | 31.08 | 33.32 | 34.89 | 37.28 |
| Shares outstanding (M) | 161 | 161 | 153 | 146 |
From the annual statements (Yahoo Finance), in the currency the company reports in. Per-share figures use the shares at the year end. Charts and annual figures →
Key figures
| P/E | 23.4 |
| P/B | 3.5 |
| EV / EBITDA | 8.8 |
| Net debt / EBITDA | 3.9 |
| Return on equity | 14.9% |
| Profit margin | 4.3% |
| Beta 1Y | 0.29 |
| Revenue growth 1Y | +0.1% |
| Revenue CAGR 3Y | +9.4% |
| ROE avg. 3Y | 10.1% |
Ratios use the latest annual report that was public 90 days after the year end.
Dividends per share (SEK)
| 2026 | 0.90 |
| 2025 | 1.20 |
| 2024 | 1.00 |
Not investment advice. Figures may contain errors from the data source.